Senior Project Manager, Jenner Institute, University of Oxford
I studied at the University of Oxford, and have 20 years' experience in immunotherapy research, spanning academia and industry.
I worked for 12 years at Immunocore Ltd developing immunotherapeutics for cancer, and in 2013 returned to the University of Oxford where I work at the Jenner Institute, managing translational vaccine projects.
Since 2015 I have been the CSO of Ducentis Biotherapeutics Ltd, developing novel therapies for autoimmune disease and inflammation.
I am an external consultant in the fields of vaccine development including GMP manufacture, and cancer immunotherapy.
Oxford immunologist working on coronavirus vaccine: our early results look highly promising
Jul 21, 2020 14:01 pm UTC| Science
A vaccine against COVID-19 is urgently needed if were to stop the virus spreading and prevent potentially millions of further deaths. Were now one step closer to that goal. Today, we published early results from our...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight